BRCA2 and ovarian cancer: In BRCA2, one of the splicing variants BRCA2-Δ3 (Gelli et al., 2019), has been shown to be associated with a high risk of developing breast or ovarian cancer (Muller et al., 2011; Caputo et al., 2018).